Plant Sanctuary

As a rare Bundibugyo Ebola outbreak accelerates across central Africa, the Trump administration has paired aggressive border controls with an evacuation policy that keeps infected and exposed U.S. citizens off American soil—a combination that has drawn warnings from public-health specialists, legal analysts, and allied governments.

The question is not merely rhetorical. U.S. citizens retain a constitutional right to enter their country, and the Centers for Disease Control and Prevention’s (CDC) May 2026 orders explicitly exempt citizens from entry bans (CDC returning travelers guidance). Yet reporting from multiple outlets describes a practical shift: when Americans fall ill or face high-risk exposure in outbreak zones, Washington is arranging care in Germany, the Czech Republic, and a new field facility in Kenya rather than flying them to the specialized biocontainment units the United States built after earlier Ebola crises.

Outbreak context

Health authorities in the Democratic Republic of the Congo (DRC) and Uganda declared an outbreak of Ebola disease caused by the Bundibugyo virus on May 15, 2026 (WHO disease outbreak news). The World Health Organization (WHO) determined the epidemic constitutes a public health emergency of international concern on May 17 (WHO emergency committee statement). By late May, WHO reported more than 900 suspected cases in the DRC alone, with confirmed cases climbing in both countries and no approved vaccine or treatment for this strain (WHO disease outbreak news).

Against that backdrop, the administration has framed its domestic posture around a single priority: keeping Ebola out of the United States.

Border policy: who can enter

On May 18, the CDC invoked public-health authority to temporarily bar certain non-U.S. citizens who had been in the DRC, Uganda, or South Sudan within the previous 21 days (CDC returning travelers guidance). Four days later, the Department of Health and Human Services (HHS) expanded that framework to lawful permanent residents—commonly called green-card holders—through an interim final rule (CDC Title 42 update).

The CDC said the step gives the agency discretionary authority during a rapidly evolving outbreak and noted that some permanent residents may travel frequently to affected regions (CDC Title 42 update). Policy analysts at KFF described barring green-card holders as highly unusual compared with past Ebola responses, which relied on enhanced airport screening rather than broad entry suspensions (KFF Quick Takes).

U.S. citizens were not named in the entry prohibition. They may still return but must route through designated airports—including Washington Dulles, Atlanta, Houston, and New York Kennedy—for enhanced screening (CDC returning travelers guidance).

Sick Americans routed abroad

The repatriation question arose in concrete form in mid-May, when Dr. Peter Stafford, an American surgeon working at a hospital in Congo’s Ituri province, developed Ebola symptoms and tested positive (NBC News). Stafford was evacuated to Berlin’s Charité University Hospital; his wife, also a physician with exposure risk, and their four children were flown to Germany for monitoring (NBC News). Another American missionary physician, Dr. Patrick LaRochelle, was sent to Prague after exposure despite having no symptoms (NBC News).

The Washington Post reported, citing five people familiar with the response, that the White House resisted allowing Stafford to return to the United States—a claim White House spokesperson Kush Desai denied, saying the patient was flown to Germany because it is closer to eastern Congo (Ars Technica). At a CDC briefing, incident manager Dr. Satish Pillai said evacuation plans were driven by conditions on the ground and the need to mobilize quickly, while declining to address whether the White House had blocked U.S. repatriation (Ars Technica).

That pattern marked a break from the 2014–2015 West Africa epidemic, when more than half a dozen infected Americans were treated at U.S. biocontainment centers—a response then-private citizen Donald Trump publicly criticized (WRAL/AP).

The Kenya facility plan

By late May, administration officials told the Associated Press they were establishing a quarantine and treatment center in Kenya for Americans exposed to Ebola in the DRC, staffed by the Departments of Defense, State, and HHS (WRAL/AP). Officials said the site at Laikipia Air Base would help patients avoid a lengthy transatlantic evacuation and could treat the full spectrum of Ebola cases, with transfers elsewhere if needed (WRAL/AP).

Secretary of State Marco Rubio stated at a Cabinet meeting that the administration “cannot and will not allow any cases of Ebola to enter the United States” (WRAL/AP). Senior officials told reporters that symptomatic patients would be moved to third countries—not the United States—for higher-level care (CNN/KRDO).

The plan drew immediate friction in Kenya. A high court judge temporarily barred the government from establishing or operating Ebola-related facilities under agreements with the United States pending a constitutional challenge, with a hearing set for June 2 (CNN/KRDO). Kenyan doctors’ unions questioned why a country with no outbreak cases would host American patients from a zone more than 1,500 miles away (CNN/KRDO).

Denial by logistics?

Legal and medical commentators have argued the distinction between a formal travel ban and a refusal to repatriate may matter less in practice than administration officials suggest.

Infectious-disease physician Dr. Céline Gounder wrote that the Kenya policy achieves an entry block through logistics: a sick American in remote eastern Congo cannot fly commercial, and if the only government-controlled evacuation routes to Kenya or Europe, the citizen effectively cannot reach U.S. care (Gounder Substack). She noted that domestic biocontainment units treated eight of nine repatriated Americans successfully during the 2014 outbreak, while the Kenya site described by officials resembles a field hospital rather than a top-tier intensive-care network (Gounder Substack).

Dr. Craig Spencer, an emergency physician who survived Ebola in 2014, told the AP that refusing to bring American patients home for treatment in established U.S. facilities amounts to “a moral abdication of what this country owes its own” (WRAL/AP). Africa CDC, the continent’s public-health agency, similarly warned that generalized travel restrictions can discourage transparency and push movement toward unmonitored routes (Ars Technica).

Administration officials maintain that proximity saves lives and that keeping Ebola out of the United States is compatible with high-quality care (CNN/KRDO). HHS said Public Health Service officers with prior Ebola experience were deploying to Kenya as part of a coordinated interagency effort (CNN/KRDO).

What the record shows

The reporting does not describe a signed order barring U.S. citizens from entering because they are sick. Citizens remain eligible for entry, subject to screening (CDC returning travelers guidance). Green-card holders from affected countries, by contrast, are currently blocked (CDC Title 42 update).

For Americans who contract Ebola or face high-risk exposure while serving in outbreak zones, however, the administration’s stated goal—articulated repeatedly by Rubio and reflected in evacuation decisions—is to ensure no Ebola cases arrive on U.S. soil (WRAL/AP). Critics contend that policy, implemented through control of medical evacuations rather than passport checks at the border, functionally denies sick citizens access to the domestic treatment infrastructure their government built for exactly this scenario (Gounder Substack). Whether courts or Congress will intervene remains unsettled as the outbreak—and the legal challenge in Kenya—continues to unfold.

Is Trump denying sick American citizens from going home if they are sick?